Form 4: Eli Lilly Director Acquires Stock Units

Eli Lilly Director Gabrielle Sulzberger acquired stock units valued at $1,129.35 as part of her compensation.

Summary

• Gabrielle Sulzberger, a Director at Eli Lilly & Co. (LLY), acquired 4.3904 stock units on June 15, 2026.
• These stock units were acquired in lieu of cash compensation under the Lilly Directors' Deferral Plan.
• The acquired units will be settled in shares of common stock upon Ms. Sulzberger's separation from service.
• The total value of the acquired stock units was $1,129.35.
• Following this transaction, Ms. Sulzberger beneficially owns 2,995.3956 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation transaction for a director rather than a significant strategic or financial event.

Positives

• Director compensation is being structured in a way that aligns with long-term shareholding through stock units.
• The transaction indicates continued confidence and participation by a board member in the company's equity.

Future Outlook

The acquired stock units will be settled in shares of common stock following the reporting person's separation from service, indicating a long-term holding strategy for director compensation.

Industry Context

StockSavvy.ai notes that the use of stock units for director compensation is a common practice in the pharmaceutical industry, aligning board interests with shareholder value over the long term.

Stakeholder Impact

• Shareholders: The transaction reflects standard director compensation practices, potentially aligning director interests with long-term shareholder value through deferred equity.

Next Steps

• Settlement of acquired stock units in shares of common stock upon reporting person's separation from service.

Key Dates

Keywords

Eli Lilly, LLY, Form 4, Director, Stock Units, Compensation, Insider Trading, SEC Filing